Testing effectiveness (Phase 2)Study completedNCT00671970
What this trial is testing
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
Who this might be right for
GlioblastomaGliosarcoma
Duke University 57